These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36159976)

  • 1. Identification of an immune-related gene prognostic index for predicting survival and immunotherapy efficacy in papillary renal cell carcinoma.
    Chen D; Zhang C; Zang Y; Wang W; Zhang J
    Front Genet; 2022; 13():970900. PubMed ID: 36159976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune-related gene-based prognostic index for predicting survival and immunotherapy outcomes in colorectal carcinoma.
    Liang Z; Sun R; Tu P; Liang Y; Liang L; Liu F; Bian Y; Yin G; Zhao F; Jiang M; Gu J; Tang D
    Front Immunol; 2022; 13():944286. PubMed ID: 36591255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinoma.
    Dai Y; Qiang W; Lin K; Gui Y; Lan X; Wang D
    Cancer Immunol Immunother; 2021 Apr; 70(4):967-979. PubMed ID: 33089373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative bioinformatics analysis of a prognostic index and immunotherapeutic targets in renal cell carcinoma.
    Tao H; Li Z; Mei Y; Li X; Lou H; Dong L; Zhou L
    Int Immunopharmacol; 2020 Oct; 87():106832. PubMed ID: 32738597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Colon Cancer to Immunotherapy.
    Wang Z; Song J; Azami NLB; Sun M
    Front Immunol; 2022; 13():802665. PubMed ID: 35572595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of prognostic biomarkers in papillary renal cell carcinoma and PTTG1 may serve as a biomarker for predicting immunotherapy response.
    Tian X; Xu WH; Xu FJ; Li H; Anwaier A; Wang HK; Wan FN; Zhu Y; Cao DL; Zhu YP; Shi GH; Qu YY; Zhang HL; Ye DW
    Ann Med; 2022 Dec; 54(1):211-226. PubMed ID: 35037540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Immune-Related Gene Prognostic Index for Head and Neck Squamous Cell Carcinoma.
    Chen Y; Li ZY; Zhou GQ; Sun Y
    Clin Cancer Res; 2021 Jan; 27(1):330-341. PubMed ID: 33097495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A bioinformatics-based immune-related prognostic index for lung adenocarcinoma that predicts patient response to immunotherapy and common treatments.
    Wang C; Lu T; Xu R; Chang X; Luo S; Peng B; Wang J; Yao L; Wang K; Shen Z; Zhao J; Zhang L
    J Thorac Dis; 2022 Jun; 14(6):2131-2146. PubMed ID: 35813746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune Cell Infiltration and Identifying Genes of Prognostic Value in the Papillary Renal Cell Carcinoma Microenvironment by Bioinformatics Analysis.
    Liu T; Zhang M; Sun D
    Biomed Res Int; 2020; 2020():5019746. PubMed ID: 32775427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a Novel Immune-Related Gene Prognostic Index for Breast Cancer.
    Yao Y; Kong X; Liu R; Xu F; Liu G; Sun C
    Front Immunol; 2022; 13():845093. PubMed ID: 35558081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics profiling integrating a four immune-related long non-coding RNAs signature as a prognostic model for papillary renal cell carcinoma.
    Liu Y; Gou X; Wei Z; Yu H; Zhou X; Li X
    Aging (Albany NY); 2020 Jul; 12(15):15359-15373. PubMed ID: 32716909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and Validation of an Immune-Related Gene Prognostic Index for Esophageal Squamous Cell Carcinoma.
    Ji Q; Cai Y; Shrestha SM; Shen D; Zhao W; Shi R
    Biomed Res Int; 2021; 2021():7430315. PubMed ID: 34722771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma.
    Kroeze SG; Bijenhof AM; Bosch JL; Jans JJ
    Cancer Biomark; 2010; 7(6):261-8. PubMed ID: 21694464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-gene risk model in papillary renal cell carcinoma: a robust likelihood-based survival analysis.
    Wang Y; Yan K; Lin J; Wang J; Zheng Z; Li X; Hua Z; Bu Y; Shi J; Sun S; Li X; Liu Y; Bi J
    Aging (Albany NY); 2020 Nov; 12(21):21854-21873. PubMed ID: 33154194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated analysis of immune-related gene subtype and immune index for immunotherapy in clear cell renal cell carcinoma.
    Bai D; Chen S; Feng H; Yin A; Lu J; Ma Y; Sugiyama H
    Pathol Res Pract; 2021 Sep; 225():153557. PubMed ID: 34329838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Immune-Related Gene Pair Index Predicts Clinical Response and Survival Outcome of Immune Checkpoint Inhibitors in Melanoma.
    Yan J; Wu X; Yu J; Kong Y; Cang S
    Front Immunol; 2022; 13():839901. PubMed ID: 35280982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Immune-Related Genes for Establishment of Prognostic Index in Hepatocellular Carcinoma.
    Li Y; Zou L; Liu X; Luo J; Liu H
    Front Cell Dev Biol; 2021; 9():760079. PubMed ID: 34796177
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of 4-genes model in papillary renal cell tumor microenvironment based on comprehensive analysis.
    Luo L; Zhou H; Su H
    BMC Cancer; 2021 May; 21(1):553. PubMed ID: 33993869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are immune checkpoint inhibitors a valid option for papillary renal cell carcinoma? A multicentre retrospective study.
    de Vries-Brilland M; Gross-Goupil M; Seegers V; Boughalem E; Beuselinck B; Thibault C; Chevreau C; Ladoire S; Barthélémy P; Negrier S; Borchiellini D; Huillard O; Geoffrois L; Gravis G; Saldana C; Thiery-Vuillemin A; Escudier B; Ravaud A; Albiges L
    Eur J Cancer; 2020 Sep; 136():76-83. PubMed ID: 32653774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel nine-microRNA-based model to improve prognosis prediction of renal cell carcinoma.
    Xu C; Zeng H; Fan J; Huang W; Yu X; Li S; Wang F; Long X
    BMC Cancer; 2022 Mar; 22(1):264. PubMed ID: 35279104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.